| Product Name | MF | CAS | Details |
|---|
| 3’-Azido-2’,3’-dideoxy-5-hydroxyuridine | C9H11N5O5 | 111495-90-0 | Details |
| 2’-Bromo-2’-deoxy-5-fluorouridine | C9H10BrFN2O5 | 32791-82-5 | Details |
| 4’-alpha-C-Allyl-2’,3’-bis(O-t-butyldimethylsilyl)uridine | C24H44N2O6Si2 | 512184-18-8 | Details |
| 5’-Deoxy-5’-N,N-diethylaminothymidine | C14H23N3O4 | 2305415-88-5 | Details |
| AR-A 2 | C27H36N4O2 | 220051-79-6 | Details |
| AM-6494 | C22H21F2N5O3S | 1874232-80-0 | Details |
| Anti-parasitic agent 3 | C21H22FN5O3 | 2366983-10-8 | Details |
| 2’-Deoxy-2’-fluoro-N6-methyladensoine | C11H14FN5O3 | 134444-58-9 | Details |
| 3’-Deoxy-5’-O-(4,4’-dimethoxytrityl)-3’-fluorouridine | C12H4Cl4F3N5O4 | 129015-60-7 | Details |
| 8-Aza-2’-deoxyguanosine | C9H12N6O4 | 4546-73-0 | Details |
| N2-iBu-5’-O-DMTr-2’-O-hexadecanyl guanosine | C51H69N5O8 | 2382942-31-4 | Details |
| 2’-Deoxy-N2-isopropyl guanosine | C13H19N5O4 | 201528-73-6 | Details |
| AMPK activator 1 | C32H33F3N4O3 | 1152423-98-7 | Details |
| 2’,3’,5’-Tri-O-acetyl-6-S-methyl-6-thio-guanosine | C17H21N5O7S | 80681-58-9 | Details |
| 3’,5’-Di-O-acetyl-2’-deoxy-5,N3-dimethyl uridine | C15H20N2O7 | 144874-49-7 | Details |
| 5’-Deoxy-5’-(4-morpholinyl)thymidine | C14H21N3O5 | 2305415-93-2 | Details |
| 5-A-RU hydrochloride | C9H17ClN4O6 | 134452-11-2 | Details |
| 2-Amino-2’,3’-bis-O-(2-methoxyethyl) ? adenosine | C16H26N6O6 | 847647-19-2 | Details |
| N6-Ethyl-2’-deoxyadenosine | C12H17N5O3 | 136050-93-6 | Details |
| ALK-IN-5 | C24H25FN6O3 | 2351929-66-1 | Details |
| BAY-784 | C29H26ClF4N3O5S2 | 1631164-24-3 | Details |
| Bombesin acetate(31362-50-2 free base) | C73H114N24O20S | 1222319-87-0 | Details |
| 2’-O-Hexadecanyl adenosine | C26H45N5O4 | 211690-85-6 | Details |
| Fenebrutinib HCl | C37H45ClN8O4 | 2128304-54-9 | Details |
| 2’-O-Hexadecanyl guanosine | C26H45N5O5 | 2382942-29-0 | Details |
| 2-Methyl-2’-deoxyadenosine | C11H15N5O3 | 110952-90-4 | Details |
| AMG 487 (S-enantiomer) | C32H28F3N5O4 | 473720-30-8 | Details |
| Saralasin acetate(34273-10-4 free base) | C44H71N13O13 | 39698-78-7 | Details |
| Anticonvulsant agent 1 | C10H14F2N2O2 | 357336-17-5 | Details |
| 3-Formylindole-2’-deoxyriboside | C14H15NO4 | 460355-03-7 | Details |
| 1’,2’,3’,5’-Tetra-O-benzoyl-2’-beta-C-ethynyl-D- ribofuranose | C35H26O9 | 1567898-12-7 | Details |
| 2’-Deoxy-N6-(3-methoxybenzyl)adenosine | C18H21N5O4 | 1947400-98-7 | Details |
| 3’-O-(2-Methoxyethyl)uridine | C12H18N2O7 | 870599-31-8 | Details |
| 5-Azidomethyl-2’,3’,5’-tri-O-benzoyl uridine | C31H25N5O9 | 1884334-72-8 | Details |
| 2’-Deoxy-2’-fluoro-3’,5’-bis-O-TBDMS-uridine | C21H39FN2O5Si2 | 139878-36-7 | Details |
| A-9758 | C25H23Cl2F3N2O3 | 2055271-22-0 | Details |
| 8-Methyl-2’-deoxyguanosine | C11H15N5O4 | 85819-69-8 | Details |
| Asthma relating compound 1 | C17H19N3O3S2 | 120165-51-7 | Details |
| Cefalonium Dihydrate(5575-21-3 free base) | C20H20N4O6S2 | 1385046-35-4 | Details |
| 3’-Deoxy-5’-O-(4,4’-dimethoxytrityl)-3’-fluorouridine-2’-CED-phosphoramidite | C12H5Cl3F3N5O4 | 129015-63-0 | Details |
| 3’,5’-Bis(O-t-butyldimethylsilyl)-4’-C-hydroxymethyl thymidine | C23H44N2O6Si2 | 179178-45-1 | Details |
| 2’-Deoxy-2’-fluoro-5-methyl-4’-thio-a-D-arabinouridine | C10H13FN2O4S | 294868-24-9 | Details |
| 5’-O-TBDPS-2,2’-anhydrouridine | C25H28N2O5Si | 175013-46-4 | Details |
| AZ12601011 | C19H15N5 | 2748337-86-0 | Details |
| β-NF-JQ1 | C45H42ClN5O6S | 2380000-55-3 | Details |
| Thymosin β4 acetate(75591-33-4 free base) | 1346423-89-9 | Details |
| 1-[[2-Hydroxy-1-(hydroxy ? methyl)ethoxy]methyl]cytosine | C8H13N3O4 | 87892-46-4 | Details |
| LTD4 antagonist 1 | C31H32F3N3O5S | 136564-67-5 | Details |
| 2-Chloro-N6-cyclopentyl 2’-deoxy- ? adenosine | C15H20ClN5O3 | 215108-39-7 | Details |
| 3’-O-(t-Butyldimethylsilyl)-2’-O-(2-methoxyethyl) uridine | C18H32N2O7Si | 1345716-52-0 | Details |
| 2’,3’,5’-Tri-O-acetyl-N3-methyluridine | C16H20N2O9 | 64623-26-3 | Details |
| 3’,5’-Di-O-acetyl-2’-deoxy-N3-methyl uridine | C14H18N2O7 | 2305416-14-0 | Details |
| 3’-O-t-Bulyldimethylsilyl-4’-C-hydroxymethylthymidine | C17H30N2O6Si | 139887-99-3 | Details |
| 5’-Deoxy-5’-furfurylamino ? thymidine | C15H19N3O5 | 2305416-15-1 | Details |
| N2-Isobutyryl-(S)-9-(2,3-dihydroxypropyl)-guanine | C12H17N5O4 | 885322-02-1 | Details |
| β3-AR agonist 1 | C22H28N4O4S | 1283125-73-4 | Details |
| ABT-546 | C30H48N2O6 | 212481-66-8 | Details |
| 2’,3’-Isopropylidene-5-hydroxyuridine | C12H16N2O7 | 20406-82-0 | Details |
| 2’-Deoxy-N6-(4-methoxybenzyl)adenosine | C18H21N5O4 | 157640-47-6 | Details |
| 2’-O-Acetyl-5’-O-benzoyl-3’-O-methyl-5-methyluridine | C20H22N2O8 | 2305415-91-0 | Details |
| Antimicrobial Compound 1 | C18H30BrNO2 | 15237-83-9 | Details |
| AR453588 | C25H25N7O2S2 | 1065609-00-8 | Details |
| 2’-Deoxy-5-methoxyuridine | C10H14N2O6 | 37805-95-1 | Details |
| 2’-Deoxy-N2,N2-diethyl ? guanosine | C14H21N5O4 | 236389-19-8 | Details |
| 2’-Deoxy-N6-cyclopentyladenosine | C15H21N5O3 | 170711-45-2 | Details |
| 3’-O-(2-Methoxyethyl)-5-methyluridine | C13H20N2O7 | 303197-29-7 | Details |
| 5-Aminomethyl-2’,3’-di-O-isopropylidene 2-thiouridine | C13H19N3O5S | 1428903-07-4 | Details |
| 5’-O-(4,4’-Dimethoxytrityl)-3’-O-methyluridine | C31H32N2O8 | 127212-40-2 | Details |
| 4'-Ethynyl-2'-deoxyadenosine | C12H13N5O3 | 306305-07-7 | Details |
| N2-iso-Butyryl-8-azaguanosine | C13H18N6O6 | 2328168-83-6 | Details |
| AHR antagonist 5 | C25H25ClFN7 | 2247953-39-3 | Details |
| Tidembersat | C20H19F2NO4 | 175013-73-7 | Details |
| Itch-Targeting Compound 1 | C25H36ClN3O3 | 793674-76-7 | Details |
| 2-O-benzoyl-3-O-t-butyldiphenylsilyl-L-threonolactone | C27H28O5Si | 1446785-28-9 | Details |
| 3’-O-(t-Butyldimethylsilyl)-2’-O-(2-methoxyethyl)-5-methyluridine | C19H34N2O7Si | 1221967-92-5 | Details |
| 5’-Deoxy-5’-N-(2-chloroethyl)aminothymidine | C12H18ClN3O4 | 2305415-99-8 | Details |
| N4-Benzoyl-5’-O-DMT-3’-O-(2-methoxyethyl)-5-methylcytidine | C41H43N3O9 | 256223-98-0 | Details |
| 2’-Chloro-N6-benzyl adenosine | C17H18ClN5O4 | 23558-62-5 | Details |
| BIIL-260 hydrochloride | C30H31ClN2O3 | 192581-24-1 | Details |
| 3’-Deoxy-N6-ethyladenosine | C12H17N5O3 | 3608-60-4 | Details |
| 7-Methoxy-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline | C13 H19 N O | 41381-73-1 | Details |
| 2-Deoxy-2’-deoxy-5’-(4,4’-dimethoxytrityl)uridine | C30H30N2O6 | 151503-26-3 | Details |
| A 83-01 sodium salt | C25H20N5NaS | 2828431-89-4 | Details |
| AhR modulator-1 | 115039-00-4 | Details |
| 2’,3’,5’-Tri-O-acetyl-5,N3-dimethyl uridine | C17H22N2O9 | 201421-00-3 | Details |
| 5-Azidomethyl-2’-beta-methyl-2’,3’,5’-tri-O-benzoyluridine | C32H27N5O9 | 2305416-08-2 | Details |
| 5’-Deoxy-5’-N,N-dimethylaminothymidine | C12H19N3O4 | 162466-79-7 | Details |
| N2-iso-Butyroyl-5’-O-DMT-3’-O-(methoxyethyl)guanosine | C38H43N5O9 | 256224-05-2 | Details |
| 8-Methyl-2’-deoxyadenosine | C11H15N5O3 | 85562-60-3 | Details |
| N1-Methyl ara-uridine | C10H14N2O6 | 17676-62-9 | Details |
| BACE1-IN-4 | C21H23F2N5O4S2 | 2361157-92-6 | Details |
| Alverine hydrochloride | C20H28ClN | 5982-87-6 | Details |
| VCH-916 free acid(1200133-34-1 free base) | C26H37NO4S | 914778-92-0 | Details |
| AFP464 free base | C22H23F3N4O3 | 468719-52-0 | Details |
| MC-4R Agonist 1 | C30H38ClF2N3O2 | 455957-28-5 | Details |
| ACHN-975 TFA | C22H24F3N3O6 | 1410809-37-8 | Details |
| 2’-Deoxy-N2-cyclopentyl guanosine | C15H21N5O5 | 1353757-90-0 | Details |
| 3’-N-Acetyl-3’-amino-3’-deoxy-2’,5’-di-O-acetyluridine | C15H19N3O8 | 2305416-09-3 | Details |
| 4’-Methylthymidine | C11H16N2O5 | 139925-84-1 | Details |
| N2-iso-Butyroyl-3’-O-(methoxyethyl)guanosine | C17H25N5O7 | 256224-04-1 | Details |
| Product Total： Product Page： | ||||
| 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 | ||||